Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities:    
Net loss $ (56,076) $ (27,260)
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:    
Depreciation and amortization 7,111 5,725
Stock-based compensation 12,501 8,277
Change in fair value of warrant liabilities (2,125) (24,225)
Impairment of intangible assets 20,753  
Realized (gain) loss from sales of short-term investments (8) 2,162
Realized foreign exchange loss 6 6
Accretion of interest income on held-to-maturity securities (6,519) (1,094)
Deferred tax benefit (1,466) (772)
Loss on disposal of property and equipment 48 68
Bad debt expense 163 0
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (6,032) (5,255)
Accounts receivable (10,254) (5,347)
Other non-current assets 4 (663)
Operating right-of-use assets/lease liabilities 379 611
Accounts payable and accrued expenses 9,049 9,900
Deferred revenue 117 737
Net cash used in operating activities (32,349) (37,130)
Cash Flows From Investing Activities:    
Acquisitions, net of cash acquired 0 (48,101)
Investment in joint venture (39) (190)
Purchase of property and equipment (2,109) (730)
Proceeds from disposal of property and equipment 138 0
Purchase of short-term investments (135) (729)
Proceeds from sales of short-term investments 20,532 258,377
Purchase of held-to-maturity investments (265,835) (227,287)
Proceeds from maturities of held-to-maturity investments 264,537 98,000
Net cash provided by investing activities 17,089 79,340
Cash Flows From Financing Activities:    
Proceeds from the exercise of common stock options 70 87
Taxes paid related to net share settlement of equity awards (146) (1,171)
Net cash used in financing activities (76) (1,084)
Effect of foreign exchange rate changes on cash balances (66) 72
Net (decrease) increase in cash and cash equivalents and restricted cash (15,402) 41,198
Cash and cash equivalents and restricted cash - beginning 44,423 3,225
Cash and cash equivalents and restricted cash - ending 29,021 44,423
Reconciliation to consolidated balance sheets    
Cash and cash equivalents [1] 27,873 41,338
Restricted cash (1) [2] 1,148 3,085
Total 29,021 44,423
Supplemental cash flow information    
Income taxes 16 0
Non-cash investing and financing activities:    
New leases under ASC 842 entered into during the period 9,760 6,364
Common stock issued for settlement of earn-out $ 1,785 $ 0
[1] Prior year amounts have been updated to conform to current period presentation.
[2] Prior year amounts have been updated to conform to current period presentation.